Article info

Download PDFPDF

Response to: Correspondence on ‘Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients’ by Trahtemberg et al
Free

Authors

  1. Correspondence to Professor Marvin J Fritzler, Medicine, University of Calgary Cumming School of Medicine, Calgary, Canada; fritzler{at}ucalgary.ca
View Full Text

Citation

Fritzler MJ, Trahtemberg U on behalf of the COVID-19 Longitudinal Biomarkers of Lung Injury (COLOBILI) study group
Response to: Correspondence on ‘Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients’ by Trahtemberg et al

Publication history

  • Received November 3, 2021
  • Accepted November 4, 2021
  • First published November 22, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.